Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intravenous bubble traps and cardiomyopathy: best can be the enemy of good.

Anaesthesia reports·2022
Same author

"Dirty Harry" syncope.

Canadian Medical Association journal·2010
Same author

Rectal passage of intestinal endometriosis.

Digestive diseases and sciences·2001
Same author

Screening colonoscopy: is it time?

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2000
Same author

Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome.

The American journal of gastroenterology·1999
Same author

Should all people over the age of 50 have regular fecal occult-blood tests? Postpone population screening until problems are solved.

The New England journal of medicine·1998
Same journal

Impact of virtual case conferences between primary care clinicians and an interdisciplinary chronic pain clinic.

Canadian family physician Medecin de famille canadien·2026
Same journal

Canadian family physician Medecin de famille canadien·2026
Same journal

Predictors of high-performing family medicine clinics: Prospective cohort study in Alberta.

Canadian family physician Medecin de famille canadien·2026
Same journal

Acetylsalicylic acid use for artial fibrillation and bleeding risk.

Canadian family physician Medecin de famille canadien·2026
Same journal

Clinical practice guidelines: Important tools to teach the art of medicine.

Canadian family physician Medecin de famille canadien·2026
Same journal

Paratonia in advanced dementia: Challenges and evidence-based interventions.

Canadian family physician Medecin de famille canadien·2026
See all related articles

Related Experiment Video

Updated: Jun 4, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

Acetaminophen liver injury.

J B Simon

    Canadian Family Physician Medecin De Famille Canadien
    |January 29, 2011
    PubMed
    Summary
    This summary is machine-generated.

    Acetaminophen overdose can cause fatal liver damage. Prompt treatment with N-acetylcysteine (Mucomyst) within 8-12 hours effectively prevents this severe hepatic injury.

    More Related Videos

    Partial Lobular Hepatectomy: A Surgical Model for Morphologic Liver Regeneration
    05:37

    Partial Lobular Hepatectomy: A Surgical Model for Morphologic Liver Regeneration

    Published on: May 31, 2018

    Related Experiment Videos

    Last Updated: Jun 4, 2026

    Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
    09:44

    Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

    Published on: November 27, 2019

    Partial Lobular Hepatectomy: A Surgical Model for Morphologic Liver Regeneration
    05:37

    Partial Lobular Hepatectomy: A Surgical Model for Morphologic Liver Regeneration

    Published on: May 31, 2018

    Area of Science:

    • Toxicology
    • Hepatology
    • Pharmacology

    Background:

    • Acetaminophen overdose is a common cause of acute liver failure.
    • A toxic metabolite mediates acetaminophen-induced liver necrosis.
    • Hepatic injury typically manifests 1-3 days after ingestion of 10-15g of acetaminophen.

    Purpose of the Study:

    • To highlight the mechanism of acetaminophen-induced liver injury.
    • To emphasize the critical time window for effective treatment.
    • To underscore the role of N-acetylcysteine in preventing acetaminophen hepatotoxicity.

    Main Methods:

    • Review of existing literature on acetaminophen toxicity.
    • Analysis of clinical presentation and laboratory findings in acetaminophen overdose.
    • Evaluation of the efficacy of N-acetylcysteine as an antidote.

    Main Results:

    • Acetaminophen overdose leads to hepatocellular necrosis via a toxic intermediate.
    • Elevated aminotransferases are characteristic indicators of liver damage.
    • N-acetylcysteine (Mucomyst) administration is highly effective in preventing liver damage.
    • Treatment efficacy is time-dependent, requiring administration within 8-12 hours of ingestion.

    Conclusions:

    • Prompt medical intervention is crucial for preventing fatal acetaminophen-induced liver necrosis.
    • N-acetylcysteine is a life-saving antidote when administered within the critical time frame.
    • Early recognition and treatment of acetaminophen overdose can avert severe hepatotoxicity.